Join us on November 13, for a webinar from the ISCT Process Development & Manufacturing Committee, on "Visible Particulates in Cell and Gene Therapy: Challenges and Perspectives in Risk Assessment." This session, sponsored by Gateway Analytical, seeks to explore the unique challenges posed by visible particulates in low-unit cell and gene therapy (CGT) batches. As regulatory concerns mount and traditional standards fall short, our expert panel will share insights from various stakeholders, including manufacturers, service providers, and regulatory consultants. Discover the operational impacts of lot rejection, learn about best practices for managing particulate risk, and delve into regulatory expectations. This webinar will focus on practical strategies and best practices while providing actionable approaches for managing visible particulates. Participants will gain valuable insights into navigating these challenges in their work, ultimately leading to improved outcomes in cell and gene therapy manufacturing. Join us to engage with industry leaders, identify knowledge gaps, and contribute to a dialogue that prioritizes patient safety while addressing the complexities of CGT manufacturing. Don't miss this opportunity to be part of an essential conversation shaping the future of cell and gene therapy quality standards!